Stone X Group Inc. Bio Restorative Therapies, Inc. Transaction History
Stone X Group Inc.
- $1.02 Billion
- Q2 2024
A detailed history of Stone X Group Inc. transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 50,100 shares of BRTX stock, worth $80,160. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,100
Previous 34,850
43.76%
Holding current value
$80,160
Previous $48,000
112.5%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BRTX
# of Institutions
14Shares Held
249KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA52.3KShares$83,7390.0% of portfolio
-
Wealth Alliance Mellville, NY40KShares$64,0000.01% of portfolio
-
Ubs Group Ag27.8KShares$44,5000.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.5KShares$32,7550.0% of portfolio
-
State Street Corp Boston, MA20.5KShares$32,7340.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $5.84M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...